ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Dafalgan, Brausetabletten 500 mg - 40
47503001 UPSA Switzerland AG
Dafalgan, Brausetabletten 500 mg03.12.1986
  03.12.1986
Paracetamol (N02BE01)12.01.2006
WHO-DDD 
01.01.10.40
01.01.10. 
B  
Yes 
IPCI
3.16No
    
10 %12.65
7680475030011Synthetika
  
Composition
paracetamolum 500 mg, acidum citricum, natrii hydrogenocarbonas, natrii carbonas, sorbitolum 126.1 mg, E 211 50 mg, aromatica (Grapefruit/Orange) cum glucosum 0.83 mg et fructosum 0.96 mg et saccharum 0.28 mg, saccharinum natricum, povidonum K 30, natrii docusas, pro compresso corresp. natrium 197 mg.
Teilbarkeit
 Nein 
 Ja 
 Ja 
 -- 
   
 
 
th_part
Active AgentDose
Paracetamol500 mg
BAG: Active AgentDose
Paracetamol500 mg
Inactive agentsDoseadditional_information
Citric Acid  
Aromatica (Grapefruit/orange) cum Glucosum0.83 mg 
E 21150 mgconserv.
Fructosum0.96 mg 
Sodium Carbonate  
Natrii Docusas  
Sodium Hydrogen Carbonate  
Povidonum K30  
Pro Compresso  
Saccharinum Natricum  
Saccharum0.28 mg 
Sorbitol126.1 mg 
 
Source
Data was imported : 06.06.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home